Gene-Synthesis Firms Set Up Biosecurity Protocol

Blue Heron Biotechnology, DNA2.0, GeneArt, GenScript, and Integrated DNA Technologies have created the International Gene Synthesis Consortium (IGSC).

Sigma-Aldrich and Sangamo Biosciences Broaden Agreement Related to Zinc-Finger Technology

Sigma-Aldrich and Sangamo BioSciences enacted an expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA...

DNA2.0 Reveals Intricacies Involved in Optimized Gene Design

Firm reports in PLoS ONE the identification of codon-choice design principles that allow greater protein expression.

Scientists Create Targeted Knockout Rats Using Sangamo’s Zinc Finger Nuclease Technology

Rats had permanent, heritable gene mutations, which will help scientists develop novel genetically modified animal models of human disease.

Sigma-Aldrich to Provide Gene Synthesis Services to Gene Oracle

Sigma-Aldrich will supply services to and exclusively provide custom oligonucleotides to Gene Oracle. The companies co-market GeneIOS gene synthesis system and services. Sigma-Aldrich's oligonucleotides thus...

IDT Purchases VH Bio’s Oligo Segment

Deal will allow the firm to grow in the U.K. Integrated DNA Technologies (IDT) acquired VH Bio’s oligonucleotide synthesis business. Since VH Bio is located...

Oxford BioMedica to Obtain $250K to Support Gene Therapy for Stargardt Disease

StarGen will continue to be evaluated in preclinical studies. Oxford BioMedica expects to receive $250,000 from the Foundation Fighting Blindness (FFB) to advance development of...

Successful Step Made toward Synthetic Genomes

JCVI team replaced whole genome of a bacterial cell with one from another bacteria. Researchers at the J. Craig Venter Institute (JCVI) have replaced the...